A single strand conformation polymorphism-based carrier test for spinal muscular atrophy

Area of Science:

• Genetics
• Molecular Biology
• Medical Diagnostics

Background:

• Spinal muscular atrophy (SMA) is an autosomal recessive disorder affecting approximately 1 in 10,000 newborns.
• The disease is caused by mutations in the Survival Motor Neuron (SMN) gene, specifically the SMN1 gene.
• Distinguishing between the highly similar SMN1 and SMN2 genes is challenging for molecular diagnosis and carrier identification.

Purpose of the Study:

• To develop a sensitive and reliable molecular test for identifying carriers of spinal muscular atrophy (SMA).
• To enable accurate quantification of the SMN1 gene product relative to a control gene for carrier status determination.

Main Methods:

• A nonradioactive single-strand conformation polymorphism (SSCP)-based method was established for SMN1 carrier identification.
• The assay quantifies the SMN1 gene product amount compared to a control gene.
• Validation was performed on 56 obligate carriers and 20 non-carriers.

Main Results:

• The developed test demonstrated high sensitivity (96.4%) and specificity (98%) for SMN1 carrier identification.
• The assay effectively detected compound hemizygote patients, including those with a heterozygous deletion and an undetected point mutation.
• The method proved effective for carrier testing within SMA families and general population screening.

Conclusions:

• The novel SSCP-based molecular test provides a sensitive and specific tool for SMN1 carrier identification.
• This assay is valuable for genetic counseling, carrier screening in at-risk families, and population-based SMA carrier detection.
• The test's ability to identify compound hemizygotes improves diagnostic capabilities for spinal muscular atrophy.